Company
Headquarters: Singapore, Singapore
CEO: Dr. Sieu Min Heah FAMS Surgen, FRCSEd, MB BCh
S$46.1 Million
SGD as of Jan. 1, 2024
US$35.0 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. It offers endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. The company also offers treatment services for other conditions, such as haemorrhoids, anal abscesses, anal fissures, anal fistula, gallstones and inflammation of the gallbladder, inflammation of the appendix, hernias, gastric cancer, colorectal cancer, stomach cancer, colonic diverticular disease, and cysts and lipomas; and vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, it provides home care, such as medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; and general consultation and diagnostic services, including blood tests, X-Rays, ultrasound, CT Scans, and MRIs. The company operates 16 clinics in Singapore. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
HC Surgical Specialists Ltd has the following listings and related stock indices.
Stock: SGX: 1B1 wb_incandescent